Home>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>YK-4-279

YK-4-279 Sale

(Synonyms: YK 4-279) 目录号 : GC17386

YK-4-279 阻断 RNA Helicase A (RHA) 与 EWS-FLI1(致癌蛋白)的结合。 YK-4-279 诱导细胞凋亡并对各种癌细胞显示出抗增殖活性。 YK-4-279 有一个手性中心,它可以分成两种对映体。 YK-4-279可用于癌症研究。

YK-4-279 Chemical Structure

Cas No.:1037184-44-3

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥378.00
现货
10mg
¥494.00
现货
50mg
¥1,575.00
现货
100mg
¥2,247.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

实验参考方法

Cell experiment [1-3]:

Cell lines

VCaP cells, LNCaP cells

Preparation method

The solubility of this compound in DMSO is >16.35 mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37 ℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.

Reacting condition

10 μM, 48 hr

Applications

YK-4-279 inhibited ERG and ETV1 mediated transcriptional activity. YK-4-279 bound to ERG with an affinity (KD) of 11.7 μM and bound to ETV1 with an affinity of 17.4 μM. In LNCaP cells, YK-4-279 (1 μM) resulted in decreased gene expression of MMP13 without significant reduction in ETV1 levels. In VCaP cells, YK-4-279 (10 μM, 48 hours) decreased expression of PLAU, ADAM19 and PLAT mRNA. YK-4-279 inhibited VCaP (10 μM) and LNCaP (1 μM) cell invasion of HUVECs. YK-4-279 (10 μM) inhibited motility in a scratch assay in high-passage LNCaP cells. YK-4-279 showed anti-proliferative activity with the IC50 values of 1 and 8 μM in primary cell lines ES925 and GUES1. YK-4-279 induced caspase-3 activity in four ESFT cell lines (TC32, A4573, TC71, and ES925). Treatment of TC32, HEK293, HFK, and HEC with short-term (6 hours) high dose (50 μM) YK-4-279 resulted in significant apoptosis of the ESFT cells. In LNCaP-luc-M6 cells, YK-4-279 (1 μM) significantly reduced mRNA levels of several ETV1 target genes, including MMP7, MMP13, FKBP10 and GLYATL2, without affecting the expression of ETV1. YK-4-279 treatment of LNCaP-luc-M6 cells resulted in a significant decrease in cell migration.

Animal experiment [2,3]:

Animal models

SCID/bg mice bearing ESFT (orthotopic) or prostate cancer cell xenograft tumors, SCID/beige mice subcutaneously injected with LNCaP-luc-M6

Dosage form

Intraperitoneal injection, 1.5mg/dose, three times per week; 75 mg/kg YK-4-279 three times a week and 150 mg/kg YK-4-279 five times a week

Application

YK-4-279 (1.5 mg/dose i.p.) inhibited the growth of ESFT xenograft tumors. In SCID/beige mice were subcutaneously injected with LNCaP-luc-M6 cells, YK-4-279 (75 mg/kg YK-4-279 three times a week and 150 mg/kg YK-4-279 five times a week) reduced tumor growth and inhibited lung metastasis. YK-4-279 treatment resulted in decreased gene expression of MMP7, GLYATL2 and FKBP10 in LNCaP-luc-M6 animals.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Rahim S, Beauchamp E M, Kong Y, et al. YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion[J]. PloS one, 2011, 6(4): e19343.

[2]. Erkizan H V, Kong Y, Merchant M, et al. A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma[J]. Nature medicine, 2009, 15(7): 750-756.

[3]. Rahim S, Minas T, Hong S H, et al. A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model[J]. PloS one, 2014, 9(12): e114260.

产品描述

YK 4-279 is an inhibitor of RNA Helicase A (RHA) binding to the oncogenic transciption factor EWS-FLI1.

EWS-FLI1 is a disordered protein that precludes standard structure-based small-molecule inhibitor design. EWS-FLI1 binding to RNA helicase A (RHA) is important for its oncogenic function.

In vitro: ESFT cells treated with YK-4-279 showed a dissociation of EWS-FLI1 from RHA by 10 mM, consistent with the KD value. The EWS-FLI1–transfected cells showed a dose-dependent decrease in promoter activity when treated for 18 h with 3 mM and 10 mM YK-4-279. YK-4-279 was relatively specific for ESFT cells as compared to the nontransformed HEK293 cells [1].

In vivo: The tumor growth rate of YK-4-279–treated mice bearing CHP-100 was lower than that in mice having PC3 prostate tumors. The cumulative data from five independent experiments with the ESFT xenografts (TC71 and CHP-100) show a marked overall tumor reduction in the YK-4-279–treated mice. Pathological analysis of mice treated with YK-4-279 did not show any signs of toxicity, except for sterile inflammatory lesions in the abdominal cavities of mice [1].

Clinical trial: No clinical data are available currently.

Reference:
[1] Erkizan HV, Kong Y, Merchant M, Schlottmann S, Barber-Rotenberg JS, Yuan L, Abaan OD, Chou TH, Dakshanamurthy S, Brown ML, Uren A, Toretsky JA.  A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma. Nat Med. 2009;15(7):750-6.

Chemical Properties

Cas No. 1037184-44-3 SDF
别名 YK 4-279
化学名 4,7-dichloro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1H-indol-2-one
Canonical SMILES COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O
分子式 C17H13Cl2NO4 分子量 366.2
溶解度 ≥ 16.35 mg/mL in DMSO, ≥ 24.25 mg/mL in EtOH with ultrasonic 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 2.7307 mL 13.6537 mL 27.3075 mL
5 mM 0.5461 mL 2.7307 mL 5.4615 mL
10 mM 0.2731 mL 1.3654 mL 2.7307 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置